Financials Fortrea Holdings Inc.

Equities

FTRE

US34965K1079

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-05-10 pm EDT 5-day change 1st Jan Change
33.03 USD -7.76% Intraday chart for Fortrea Holdings Inc. -11.71% -5.36%

Valuation

Fiscal Period: December 2023 2024 2025 2026
Capitalization 1 3,099 2,952 - -
Enterprise Value (EV) 1 4,583 3,976 3,803 3,619
P/E ratio -873 x -315 x 34 x 23.3 x
Yield - - - -
Capitalization / Revenue 1 x 0.96 x 0.93 x 0.9 x
EV / Revenue 1.47 x 1.29 x 1.2 x 1.11 x
EV / EBITDA 17.1 x 14 x 9.86 x 8.78 x
EV / FCF 36.1 x 41 x 28.3 x 24.9 x
FCF Yield 2.77% 2.44% 3.54% 4.02%
Price to Book 1.78 x 1.51 x 1.39 x 1.28 x
Nbr of stocks (in thousands) 88,800 89,374 - -
Reference price 2 34.90 33.03 33.03 33.03
Announcement Date 3/11/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 3,109 3,080 3,164 3,271
EBITDA 1 - 267.3 283 385.7 412
EBIT 1 - 170.9 242.1 350 381.7
Operating Margin - 5.5% 7.86% 11.06% 11.67%
Earnings before Tax (EBT) 1 237 1.1 -21.01 109.6 168.9
Net income 1 192.9 -3.4 -15.77 83.11 127.2
Net margin - -0.11% -0.51% 2.63% 3.89%
EPS 2 - -0.0400 -0.1050 0.9725 1.415
Free Cash Flow 1 - 127.1 97 134.6 145.5
FCF margin - 4.09% 3.15% 4.25% 4.45%
FCF Conversion (EBITDA) - 47.55% 34.27% 34.89% 35.32%
FCF Conversion (Net income) - - - 161.92% 114.37%
Dividend per Share 2 - - - - -
Announcement Date 5/15/23 3/11/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 793 776.4 775.4 754.6 788.3 767.1 781.7 775.6
EBITDA 1 72.5 70.5 67.2 39.68 59.68 86.41 98.97 84.18
EBIT 1 63 45.9 43.3 34.66 45.89 71.31 86.26 75.82
Operating Margin 7.94% 5.91% 5.58% 4.59% 5.82% 9.3% 11.04% 9.77%
Earnings before Tax (EBT) 1 - - -41 -37.83 -20.22 7.962 20.25 22
Net income 1 28.3 -13.1 -36 -28.53 -15.29 5.946 15.42 16.79
Net margin 3.57% -1.69% -4.64% -3.78% -1.94% 0.78% 1.97% 2.17%
EPS 2 0.3200 -0.1500 -0.4100 -0.3200 -0.1700 0.0650 0.2067 0.1900
Dividend per Share 2 - - - - - - - -
Announcement Date 8/14/23 11/13/23 3/11/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 - 1,483 1,024 851 667
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) - 5.55 x 3.618 x 2.207 x 1.618 x
Free Cash Flow 1 - 127 97 135 146
ROE (net income / shareholders' equity) - 4.9% 4.85% 8.53% 9.42%
ROA (Net income/ Total Assets) - 2.88% 2.05% 3.97% 4.84%
Assets 1 - -118 -770.8 2,095 2,628
Book Value Per Share 2 - 19.60 21.90 23.80 25.80
Cash Flow per Share 2 - 1.970 1.310 2.160 2.470
Capex 1 - 40.3 81.8 56.7 72
Capex / Sales - 1.3% 2.65% 1.79% 2.2%
Announcement Date 5/15/23 3/11/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
33.03 USD
Average target price
39.79 USD
Spread / Average Target
+20.45%
Consensus
  1. Stock Market
  2. Equities
  3. FTRE Stock
  4. Financials Fortrea Holdings Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW